280 results on '"Camma, C."'
Search Results
2. Metagenomic and volatile profiles of ripened cheese obtained from dairy ewes fed a dietary hemp seed supplementation
3. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
4. Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to patients with advanced solid tumours
5. Validation of a fast real-time PCR method to detect fraud and mislabeling in milk and dairy products
6. Detection of Anaplasma phagocytophilum genotypes that are potentially virulent for human in wild ruminants and Ixodes ricinus in Central Italy
7. Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network
8. Long-term therapy with intravenous human albumin increase survival in patients with decompensated cirrhosis and refractory ascites
9. First and further liver decompensation in patients with metabolic-dysfunction associated steatotic liver disease: what clinical impact?
10. Clinical outcomes of metabolic liver disease versus non-alcoholic fatty liver disease: a meta-analysis of observational studies
11. RESIST-NASH: a regional network for identification and referral of masld patients at risk for liver fibrosis
12. Hepatitis B surface antigen positive donors for liver recipients with hepatocellular carcinoma: a single centre experience
13. Cholestasis impacts on performance of non invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis and compensated advanced chronic liver disease
14. A Markov model unveiling the impact of Resmetirom on the natural history of MASLD patients with baseline significant or severe liver fibrosis
15. Editorial: proton pump inhibitor use in cirrhosis—a piece of the puzzle
16. Percutaneous and surgical treatment of pyogenic liver abscesses: Observation over a 21-year period in 148 patients
17. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy
18. Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. (Liver Disease)
19. RESIST Criteria: A biochemical algorithm to reduce the number of unnecessary upper endoscopies for the evaluation of portal hypertension in compensated HBV-cirrhotic patients
20. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease
21. Risk factors for viral reactivation in patients with overt or occult Hepatitis B Virus infection receiving immunosuppressive treatments: A systematic review and meta-analysis with decision curve analysis
22. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
23. Serum procalcitonin predicts mortality independently of the presence of ACLF in patients with cirrhosis and ascites hospitalized for suspicious infection and treated with empiric antibiotic therapy
24. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
25. Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?
26. OC.02.3 SEQUENTIAL THERAPY IN THE MANAGEMENT OF MODERATE-TOSEVERE ULCERATIVE COLITIS: MARKOVIAN MODELS TO GUIDE TREATMENT CHOICES
27. Pharmacological interventions effect on liver histology in nonalcoholic steatohepatitis: a network meta-analysis
28. AGILE-3 Score for the diagnosis of advanced fibrosis and for predicting liver-related events in nonalcoholic fatty liver disease
29. Transjugular intra-hepatic portosystemic shunt (TIPS) in elderly patients: preliminary analysis of a multicenter retrospective cohort.
30. Outcomes of three lines Atezolizumab plus Bevacizumab-based sequential treatment for hepatocellular carcinoma: a simulation model
31. OC-10Liver-related and extrahepatic events occurrence in patients with nonalcoholic fatty liver disease: a competing risk analysis
32. OC-06A cholestatic pattern predicts liver-related events in patients with nonalcoholic fatty liver disease
33. AF.87 RESIST-HCV CRITERIA ARE ABLE TO RULE OUT ESOPHAGEAL VARICES PROGRESSION IN PATIENTS WITH HCV CIRRHOSIS TREATED BY DIRECT-ACTING ANTIVIRAL AGENTS(DAAS)
34. AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY
35. OC.09.4 PREVALENCE OF NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) IN INFLAMMATORY BOWEL DISEASE: THE ROLE OF METABOLIC FACTORS, INTESTINAL INFLAMMATION AND GENETIC PHENOTYPE
36. OC.04.3 FIRST-LINE IMMUNE CHECKPOINT INHIBITOR-BASED SEQUENTIAL THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A RATIONALE FOR FUTURE TRIALS
37. Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma
38. Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?
39. A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease
40. NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease
41. RESIST-HCV criteria are able to rule out esophageal varices progression in patients with HCV cirrhosis treated by Direct-acting Antiviral Agents(DAAs)
42. GEMS, a GEnetic and Metabolic Staging predicting the outcome of non-alcoholic fatty liver disease
43. Molecular detection of Babesia equi and Babesia caballi in horse blood by PCR amplification of part of the 16S rRNA gene
44. T06.01.23 STEATOSIS AS A PREDICTIVE MARKER OF CARDIOVASCULAR ALTERATIONS IN A MEDITERRANEAN PRIMARY CARE COHORT
45. T06.01.2 ESBLE AND MRSA FAECAL CARRIAGE IN CIRRHOTIC PATIENTS: A RETROSPECTIVE STUDY ON CLINICAL OUTCOMES BEFORE AND AFTER LIVER TRANSPLANTATION
46. T04.01.11 PREVALENCE OF NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) IN INFLAMMATORY BOWEL DISEASE: THE IMPACT OF TRADITIONAL RISK FACTORS, INTESTINAL INFLAMMATION AND GENETIC PHENOTYPE
47. T03.01.16 EFFICACY OF LUMEN APPOSING METAL STENTS VS SELF-EXPANDABLE METAL STENTS FOR ENDOSCOPIC ULTRASOUND-GUIDED CHOLEDOCHO-DUODENOSTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
48. T03.01.13 DIAGNOSTIC PERFORMANCE OF ENDOSCOPIC ULTRASOUND THROUGH-THE-NEEDLE MICROFORCEPS BIOPSY (EUS-TTNB) OF PANCREATIC CYSTIC LESIONS: A SYSTEMATIC REVIEW WITH META-ANALYSIS
49. A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease
50. Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.